GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment in depression, today reported ...

KIGALI, Jan. 6 (Xinhua) -- After one year of advanced vocational training at China's Jinhua University of Vocational Technology (JUVT), 30 students from Rwanda Polytechnic (RP) Musanze College are now ...

GH001 cleared by FDA for U.S. clinical investigation, enabling U.S. subject enrollmentCompany to seek FDA alignment on global Phase 3 program ...

GH Research ( ($GHRS) ) just unveiled an announcement. On January 2, 2026, GH Research PLC announced that it plans to provide an update on the ...

GH001 cleared by FDA for U.S. clinical investigation, enabling U.S. subject enrollmentCompany to seek FDA alignment on global Phase 3 program replicating Phase 2b designPhase 3 initiation targeted for ...

The Cellares Cell Shuttle platform was the first to receive the FDA’s Advanced Manufacturing Technology (AMT) designation, which offers partners additional touchpoints and priority review mechanisms ...

For inspiration on how to make the most of your second reset of the school year, we checked in with contributors to The ...

Investing.com -- GH Research PLC (NASDAQ:GHRS) stock surged 28% in after-hours trading on Friday following the company’s announcement that it will provide an update on its Investigational New Drug ...

WPP Media believes so. The media-buying outlet, part of British ad giant WPP and once known as GroupM, is launching a new ...

St. Louis Metropolitan Police Department Police Chief Robert Tracy has taken on a new role as an educational consultant at ...

HHS’s move Monday to overhaul the childhood vaccine schedule without public input marks Health Secretary Robert F. Kennedy Jr ...

The FDA lifted its clinical hold on GH Research's GH001 after Phase 2b data showed rapid, durable benefits in ...